Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study
Blood and Lymphatic Cancer: Targets and Therapy · 2026-07 · Volume 16 · 1-16
DOI: 10.2147/blctt.s616235 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2026-07. Verfasst von Chen Qiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lymphoma, Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical Univers…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Lymphoma, Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University), Taiyuan, Shanxi, People's Republic of China.
- Sino-German Joint Oncological Research Laboratory, Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences), Taiyuan, Shanxi, People's Republic of China.
- Department of Thoracic Oncology, Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University), Taiyuan, Shanxi, People's Republic of China.
- Department of Hematology, Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University), Taiyuan, Shanxi, People's Republic of China.
- Pre-Medical Program, School of Arts and Sciences, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts, USA.
ORCID-Profile: Tingting Zhang
Zitieren
APA
Qiu, C., Zhang, T., Yang, X., Guo, Y., Gong, Z., & Song, D. (2026). Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study. Blood and Lymphatic Cancer: Targets and Therapy, Volume 16, 1-16. https://doi.org/10.2147/blctt.s616235
Vancouver
Qiu C, Zhang T, Yang X, Guo Y, Gong Z, Song D. Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study. Blood and Lymphatic Cancer: Targets and Therapy. 2026;Volume 16:1-16. doi:10.2147/blctt.s616235
BibTeX
@article{Qiu2026,
author = {Qiu, Chen and Zhang, Tingting and Yang, Xuejing and Guo, Yafang and Gong, Zihui and Song, Dong},
title = {Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 16},
pages = {1--16},
doi = {10.2147/blctt.s616235}
}
EUVIMED